Cargando…

Tumor mutation burden and JARID2 gene alteration are associated with short disease-free survival in locally advanced triple-negative breast cancer

BACKGROUND: In locally advanced triple-negative breast cancer (TNBC), patients who did not achieve pathologic complete response (non-pCR) after neoadjuvant chemotherapy develop rapid tumor metastasis. Tumor mutation burden (TMB) is a potential biomarker of cancer therapy, though whether it is applic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xiangmei, Li, Jingping, Yang, Qing, Wang, Yanfang, Li, Xinhui, Liu, Yunjiang, Shan, Baoen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576007/ https://www.ncbi.nlm.nih.gov/pubmed/33145271 http://dx.doi.org/10.21037/atm-20-3773

Ejemplares similares

Folate Receptor 4-Expressing T cell Is Associated with Disease-Free Survival in Patients with Esophageal Squamous Cell Carcinoma
por: Zhang, Xiangmei, et al.
Publicado: (2022)

Jarid2 is essential for the maintenance of tumor initiating cells in bladder cancer
por: Zhu, Xin-Xing, et al.
Publicado: (2017)

Inactive yet indispensable: the tale of Jarid2
por: Landeira, David, et al.
Publicado: (2011)

Changes in HER2 status and survival outcomes in patients with non-pathological complete response after neoadjuvant targeted treatment
por: Ren, Xiaofei, et al.
Publicado: (2023)

Blocking the Notch signal transduction pathway promotes tumor growth in osteosarcoma by affecting polarization of TAM to M2 phenotype
por: Ren, Shuguang, et al.
Publicado: (2020)

DNA Methylation Signature for JARID2-Neurodevelopmental Syndrome
por: Verberne, Eline A., et al.
Publicado: (2022)

Jarid1b promotes epidermal differentiation by mediating the repression of Ship1 and activation of the AKT/Ovol1 pathway
por: Sun, Xuewei, et al.
Publicado: (2019)

Function of JARID2 in bovines during early embryonic development
por: Fu, Yao, et al.
Publicado: (2017)

Regulation of oncogenic PI3-kinase signaling by JARID1B
por: Facompre, Nicole D., et al.
Publicado: (2017)

JARID2 coordinates with the NuRD complex to facilitate breast tumorigenesis through response to adipocyte‐derived leptin
por: Liu, Wei, et al.
Publicado: (2023)

SKP2 inactivation suppresses prostate tumorigenesis by mediating JARID1B ubiquitination
por: Lu, Wenfu, et al.
Publicado: (2014)

AKAP3 correlates with triple negative status and disease free survival in breast cancer
por: Esmaeili, Rezvan, et al.
Publicado: (2015)

A novel form of JARID2 is required for differentiation in lineage‐committed cells
por: Al‐Raawi, Diaa, et al.
Publicado: (2018)

Late-stage differentiation of embryonic pancreatic β-cells requires Jarid2
por: Cervantes, Sara, et al.
Publicado: (2017)

Functional Insight into and Refinement of the Genomic Boundaries of the JARID2-Neurodevelopmental Disorder Episignature
por: van der Laan, Liselot, et al.
Publicado: (2023)

Mechanisms of JARID1B Up-Regulation and Its Role in Helicobacter pylori-Induced Gastric Carcinogenesis
por: Zheng, Lixin, et al.
Publicado: (2021)

A Prognostic Gene Signature for Metastasis-Free Survival of Triple Negative Breast Cancer Patients
por: Lee, UnJin, et al.
Publicado: (2013)

MRI Radiomic Features: Association with Disease-Free Survival in Patients with Triple-Negative Breast Cancer
por: Kim, Sungwon, et al.
Publicado: (2020)

Prognostic significance of RBP2-H1 variant of JARID1B in melanoma
por: Kuźbicki, Łukasz, et al.
Publicado: (2017)

Autoregulation of JARID2 through PRC2 interaction with its antisense ncRNA
por: Al-Raawi, Diaa, et al.
Publicado: (2020)

Jarid2 promotes temporal progression of retinal progenitors via repression of Foxp1
por: Zhang, Jianmin, et al.
Publicado: (2023)

Jarid2 promotes temporal progression of retinal progenitors via repression of Foxp1
por: Zhang, Jianmin, et al.
Publicado: (2023)

Distinct binding pattern of EZH2 and JARID2 on RNAs and DNAs in hepatocellular carcinoma development
por: Wen, Zhili, et al.
Publicado: (2022)

Survival Study of Triple-Negative and Non–Triple-Negative Breast Cancer in a Brazilian Cohort
por: Gonçalves, Homero, et al.
Publicado: (2018)

The expression landscape of FOXP3 and its prognostic value in breast cancer
por: Li, Jingping, et al.
Publicado: (2022)

Hsa_circ_0002496 promotes the growth, angiogenesis, and stemness of breast cancer cells via miR‐433‐3p/YWHAZ cascade
por: Yang, Chao, et al.
Publicado: (2023)

Association between obesity with disease-free survival and overall survival in triple-negative breast cancer: A meta-analysis
por: Mei, Lin, et al.
Publicado: (2018)

Combination of pegylated liposomal doxorubicin and docetaxel as neoadjuvant therapy for breast cancer with axillary lymph node metastasis
por: Wang, Li, et al.
Publicado: (2020)

Cytotoxic T-lymphocyte infiltration and chemokine predict long-term patient survival independently of tumor mutational burden in triple-negative breast cancer
por: Katsuta, Eriko, et al.
Publicado: (2021)

Phosphorylated eIF2α predicts disease-free survival in triple-negative breast cancer patients
por: Guo, Liang, et al.
Publicado: (2017)

Clinicopathological, Treatment and Event-Free Survival Characteristics in a Moroccan Population of Triple-Negative Breast Cancer
por: Mouh, Fatima Zahra, et al.
Publicado: (2020)

A Nomogram to Predict Disease-Free Survival Following Neoadjuvant Chemotherapy for Triple Negative Breast Cancer
por: Zhu, Meizhen, et al.
Publicado: (2021)

Disease-free survival landmark analysis: a potential critical endpoint in triple-negative breast cancer
por: Zheng, Fangchao, et al.
Publicado: (2022)

PLU-1/Jarid1B contributes to estrogen-induced cell proliferation in the normal mammary gland and in breast cancer, and is required for embryonic survival
por: Catchpole, S, et al.
Publicado: (2010)

NRBP1 negatively regulates SALL4 to reduce the invasion and migration, promote apoptosis and increase the sensitivity to chemotherapy drugs of breast cancer cells
por: Yang, Chao, et al.
Publicado: (2022)

Sex-Specific Expression of the X-Linked Histone Demethylase Gene Jarid1c in Brain
por: Xu, Jun, et al.
Publicado: (2008)

Functional analysis of the breast cancer associated transcriptional repressor PLU-1/JARID1B
por: Taylor-Papadimitriou, J, et al.
Publicado: (2006)

Overexpression of JARID1B is associated with poor prognosis and chemotherapy resistance in epithelial ovarian cancer
por: Wang, Lishuang, et al.
Publicado: (2015)

Overexpression of KDM5B/JARID1B is associated with poor prognosis in hepatocellular carcinoma
por: Shigekawa, Yoshinobu, et al.
Publicado: (2018)

Comparison of the expression levels of lysine-specific demethylase 1 and survival outcomes between triple-negative and non-triple-negative breast cancer
por: Zhao, Kangrong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_r6cti0td9i3uh289t2r4dji0ok